Literature DB >> 27006394

Structure of an α-Helical Peptide and Lipopeptide Bound to the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule CD1d.

Enrico Girardi1, Jing Wang1, Dirk M Zajonc2.   

Abstract

Mouse CD1d is a nonclassical MHC molecule able to present lipids and glycolipids to a specialized subset of T cells known as natural killer T cells. The antigens presented by CD1d have been shown to cover a broad range of chemical structures and to follow precise rules determining the potency of the antigen in the context of T cell activation. Together with lipids, initial reports suggested that CD1d can also bind and present hydrophobic peptides with (F/W)XX(I/L/M)XXW. However, the exact location of peptide binding and the molecular basis for the required motif are currently unknown. Here we present the crystal structure of the first peptide identified to bind CD1d, p99, and show that it binds in the antigen-binding groove of CD1d in a manner compatible with its presentation to T cell receptors. Interestingly, the peptide adopts an α-helical conformation, which orients the motif residues toward its deep binding groove, therefore explaining the molecular requirements for peptide binding. Moreover, we demonstrate that a lipopeptide version of the same peptide is able to bind CD1d in a similar conformation, identifying another class of molecules binding this antigen-presenting molecule.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  CD1d; MHC Class I-like; T cell receptor (TCR); antigen presentation; crystal structure; glycolipid; peptides

Mesh:

Substances:

Year:  2016        PMID: 27006394      PMCID: PMC4865915          DOI: 10.1074/jbc.M115.702118

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle.

Authors:  H C Guo; T S Jardetzky; T P Garrett; W S Lane; J L Strominger; D C Wiley
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

2.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides.

Authors:  T Kawano; J Cui; Y Koezuka; I Toura; Y Kaneko; K Motoki; H Ueno; R Nakagawa; H Sato; E Kondo; H Koseki; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

Review 3.  Mouse CD1-specific NK1 T cells: development, specificity, and function.

Authors:  A Bendelac; M N Rivera; S H Park; J H Roark
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 4.  The three-dimensional structure of peptide-MHC complexes.

Authors:  D R Madden
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

5.  Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins.

Authors:  Dapeng Zhou; Carlos Cantu; Yuval Sagiv; Nicolas Schrantz; Ashok B Kulkarni; Xiaoyang Qi; Don J Mahuran; Carlos R Morales; Gregory A Grabowski; Kamel Benlagha; Paul Savage; Albert Bendelac; Luc Teyton
Journal:  Science       Date:  2003-12-18       Impact factor: 47.728

6.  Peptide binding and presentation by mouse CD1.

Authors:  A R Castaño; S Tangri; J E Miller; H R Holcombe; M R Jackson; W D Huse; M Kronenberg; P A Peterson
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

7.  Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition.

Authors:  W Zhang; A C Young; M Imarai; S G Nathenson; J C Sacchettini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

8.  Induction of an antigen-specific, CD1-restricted cytotoxic T lymphocyte response In vivo.

Authors:  D J Lee; A Abeyratne; D A Carson; M Corr
Journal:  J Exp Med       Date:  1998-02-02       Impact factor: 14.307

9.  T cell clones specific for an amphipathic alpha-helical region of sperm whale myoglobin show differing fine specificities for synthetic peptides. A multiview/single structure interpretation of immunodominance.

Authors:  K B Cease; I Berkower; J York-Jolley; J A Berzofsky
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

10.  Species Specific Differences of CD1d Oligomer Loading In Vitro.

Authors:  Daniel Paletta; Alina Suzann Fichtner; Lisa Starick; Steven A Porcelli; Paul B Savage; Thomas Herrmann
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

View more
  6 in total

1.  Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.

Authors:  Ge Ying; Jing Wang; Thierry Mallevaey; Serge Van Calenbergh; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2019-07-11       Impact factor: 5.157

Review 2.  Mechanisms and Consequences of Antigen Presentation by CD1.

Authors:  Luc Van Kaer; Lan Wu; Sebastian Joyce
Journal:  Trends Immunol       Date:  2016-09-09       Impact factor: 16.687

Review 3.  The CD1 family: serving lipid antigens to T cells since the Mesozoic era.

Authors:  Dirk M Zajonc
Journal:  Immunogenetics       Date:  2016-07-02       Impact factor: 2.846

4.  Crystal structures of lysophospholipid-bound MHC class I molecules.

Authors:  Yoko Shima; Daisuke Morita; Tatsuaki Mizutani; Naoki Mori; Bunzo Mikami; Masahiko Sugita
Journal:  J Biol Chem       Date:  2020-04-08       Impact factor: 5.157

Review 5.  CD1d-Restricted Type II NKT Cells Reactive With Endogenous Hydrophobic Peptides.

Authors:  Yusuke Nishioka; Sakiko Masuda; Utano Tomaru; Akihiro Ishizu
Journal:  Front Immunol       Date:  2018-03-15       Impact factor: 7.561

6.  Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.

Authors:  Catarina F Almeida; Srinivasan Sundararaj; Jérôme Le Nours; T Praveena; Benjamin Cao; Satvika Burugupalli; Dylan G M Smith; Onisha Patel; Manfred Brigl; Daniel G Pellicci; Spencer J Williams; Adam P Uldrich; Dale I Godfrey; Jamie Rossjohn
Journal:  Nat Commun       Date:  2019-11-20       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.